Prelude Therapeutics Incorporated (PRLD) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Prelude Therapeutics Incorporated (PRLD) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

PRLD Cash Flow Statement

Prelude Therapeutics Incorporated (PRLD) cash flow statement — 8-year operating, investing & financing cash flows

Annual Quarterly

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-15.57M	-21.68M	23.12M	-19.11M	-26.07M	-34.23M	-20.74M	-27.3M	-23.06M	-31.79M	-23.58M	-25.68M	-27.67M	-30.13M	-22.93M	-20.44M	-18.47M	-21.89M	-25.7M	-21.77M
Operating CF Margin %	-273.04%	-473.47%	409.91%	-294.08%	-	-	-518.6%	-909.87%	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	40.27%	36.65%	211.45%	29.97%	-13.09%	-7.68%	12.02%	-6.28%	16.67%	-5.5%	-2.84%	-25.66%	-49.82%	-37.63%	10.8%	6.13%	7.25%	-35.63%	-73.11%	-74.09%
Net Income	-13.92M	-10.38M	-16.46M	-19.73M	-31.23M	-32.09M	-28.73M	-32.27M	-34.74M	-31.43M	-33.08M	-30.61M	-30.43M	-27.72M	-28.64M	-29.96M	-27.37M	-29.46M	-32.84M	-30.69M
Depreciation & Amortization	353K	391K	285K	425K	433K	435K	489K	405K	452K	426K	331K	279K	723K	710K	362K	776K	749K	718K	690K	266K
Stock-Based Compensation	2.03M	2M	1.84M	2.42M	3.81M	3.83M	3.77M	5.93M	6.1M	5.55M	5.91M	6.71M	0	0	5.84M	0	0	0	0	7.03M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	-1.07M	-1.6M	0	0	0	0	0	0	0	0
Other Non-Cash Items	77K	-1K	329K	334K	170K	463K	-563K	-423K	-935K	-1.13M	608K	454K	6.37M	5.81M	258K	7.43M	7.06M	7.58M	6.78M	712K
Working Capital Changes	-4.11M	-13.69M	37.12M	-2.57M	739K	-6.88M	4.29M	-933K	6.07M	-5.21M	3.72M	-926K	-4.33M	-8.94M	-751K	1.31M	1.09M	-725K	-333K	902K
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	-154K	-1.88M	1.27M	-2.43M	-850K	-1.91M	1.81M	-213K	1.08M	631K	-465K	-472K	-1.71M	374K	-3.24M	3.73M	-840K	2K	0	4.51M
Cash from Investing	-65.5M	8.5M	-60.34M	40.09M	11.52M	62.19M	22.12M	10.73M	26.12M	31.22M	7.74M	15.04M	-75.43M	18M	1.35M	21.61M	17.18M	41.55M	-1.8M	-260.63M
Capital Expenditures	0	0	0	0	-20K	-47K	-53K	-63K	-359K	-289K	-1.13M	-591K	-983K	-810K	-393K	-916K	-758K	-952K	-297K	-659K
CapEx % of Revenue	-	-	-	-	-	-	1.32%	2.1%	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	-8.87K	-15.64K	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	8.87K	15.64K	0	0	0	0	0	0	0	0
Cash from Financing	85.82M	-314K	24.94M	-5K	37K	-160K	-34K	-131K	59K	-14K	25.24M	88K	111.34M	-269K	155K	148K	359K	153K	1.95M	711K
Debt Issued (Net)	0	0	0	0	-53K	-155K	-151K	-148K	-96K	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	90.2M	31K	74K	0	92K	0	124K	56K	0	0	24.94M	104K	111.34M	-269K	0	148K	359K	153K	1.95M	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	-4.38M	-345K	24.87M	-5K	-2K	-5K	-7K	-39K	155K	-14K	301K	-16K	0	0	155K	0	0	0	0	711K
Net Change in Cash	4.74M	-13.5M	-12.28M	20.97M	-14.52M	27.8M	1.34M	-16.69M	3.12M	-584K	9.39M	-10.55M	8.24M	-12.4M	-21.42M	1.32M	-928K	19.81M	-29.6M	-281.69M
Free Cash Flow	-15.57M	-21.68M	23.12M	-19.11M	-26.09M	-34.28M	-20.8M	-27.36M	-23.42M	-32.08M	-24.71M	-26.27M	-28.65M	-30.94M	-23.32M	-21.36M	-19.23M	-22.85M	-26M	-22.43M
FCF Margin %	-273.04%	-473.47%	409.91%	-294.08%	-	-	-519.93%	-911.97%	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	40.32%	36.74%	211.17%	30.13%	-11.44%	-6.85%	15.83%	-4.13%	18.27%	-3.67%	-5.95%	-23.03%	-49.02%	-35.44%	10.3%	4.81%	5.26%	-33.38%	-71.32%	-76.96%
FCF per Share	-0.16	-0.26	0.37	-0.25	-0.34	-0.45	-0.27	-0.36	-0.31	-0.42	-0.36	-0.39	-0.51	-0.65	-0.49	-0.45	-0.41	-0.49	-0.56	-0.48
FCF Conversion (FCF/Net Income)	1.12x	2.09x	-1.40x	0.97x	0.83x	1.07x	0.72x	0.85x	0.66x	1.01x	0.71x	0.84x	0.91x	1.09x	0.80x	0.68x	0.67x	0.74x	0.78x	0.71x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0